FINWIRES · TerminalLIVE
FINWIRES

GenFleet Therapeutics Says RAS Inhibitor Program Unrelated to RevMed IP Dispute; Shares Down 7%

By

GenFleet Therapeutics (Shanghai) (HKG:2595) said correspondence issued by Revolution Medicines on patent and trade secret disputes over RAS inhibitors is unrelated to the company, according to a Tuesday Hong Kong bourse filing.

GenFleet said all entities, products, and disputed matters referenced are "entirely unrelated" to it.

The company added GFH276, which is developed on fully independent, original, and proprietary intellectual property, with no exposure to such risks.

The company said it has built a global patent portfolio for its Pan RAS inhibitor program, with the core patent for GFH276's compound structure published on March 6, 2025, and protection expected to extend to 2044.

GenFleet's shares fell nearly 7% in recent trade.

Related Articles

Asia

Shenzhen Dobot Completes A Share Listing Filing in China

Shenzhen Dobot (HKG:2432) completed the A share listing filing to go public in China, the firm said in a statement to the Hong Kong bourse Monday.The robotics services company's shares fell nearly 1% in late morning trade Tuesday.The firm submitted application materials in regards to the proposed A share offering on the ChiNext Market of the Shenzhen Stock Exchange.The filing was accepted by the exchange, the firm said.

HKG:2432
Asia

Daido to Raise HK$11 Million via Share Subscription; Shares Rise 14%

Daido Group (HKG:0544) aims to raise net proceeds of about HK$11.4 million through a subscription of new shares under its general mandate, according to a Monday Hong Kong bourse filing.Shares of the warehouse, logistics, and trading company rose nearly 14% in morning trade Tuesday.The company agreed to issue about 5.8 million subscription shares at HK$2.00 each.The subscription price represents a premium of about 13.6% to the stock's last close and about 14.3% to the five-day average closing price, the filing showed.Proceeds will be used mainly for debt repayment and general working capital.

HKG:0544
Asia

Nine Entertainment Shares Slide After Australian Government Opens Consultation on News Bargaining Incentive

Nine Entertainment (ASX:NEC) shares fell nearly 1% in recent Tuesday trade after the Australian government opened a consultation on draft legislation to establish a News Bargaining Incentive, a policy framework designed to force major digital platforms like Meta, Google, and TikTok to pay for Australian news content.Nine Entertainment is the publisher of The Australian Financial Review and has a current commercial agreement with Google, according to an AFR report.In a Tuesday statement announcing the consultation, the government said it encourages digital platforms to enter commercial deals with news publishers "as the preferred model." However, platforms who decide not to do so will be required to pay a charge as a proportion of their revenue, with the collected levies distributed back into the news media sector.The initiative, which comes after Meta said it would not renew its commercial deals, proposes a 2.25% tax on the revenue of tech companies that do not negotiate agreements, AFR reported.Submissions on the government's consultation close on May 18.

ASX:NEC